Download PDF
Am J Perinatol 2019; 36(10): 1014-1022
DOI: 10.1055/s-0038-1675833
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Relationship between Early Antibiotic Exposure and Short-Term Growth Velocity in Premature Neonates

Brittany M. Reid
1   Division of Neonatology, Department of Pediatrics, Children's Hospital at Montefiore, Bronx, New York
,
Ruth Eisenberg
2   Division of Biostatistics, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York
,
Katie Forman
1   Division of Neonatology, Department of Pediatrics, Children's Hospital at Montefiore, Bronx, New York
,
Mariam Susan LaTuga
1   Division of Neonatology, Department of Pediatrics, Children's Hospital at Montefiore, Bronx, New York
› Author Affiliations
Further Information

Publication History

01 July 2018

01 October 2018

Publication Date:
30 November 2018 (online)

    Permissions and Reprints

Corrected by:

Erratum to: Relationship between Early Antibiotic Exposure and Short-Term Growth Velocity in Premature NeonatesAm J Perinatol 2019; 36(10): e1-e1
DOI: 10.1055/s-0039-1678577

Abstract

Objective To characterize the relationship between the duration of antibiotic administration during the first week of life and subsequent growth velocity during hospitalization.

Study Design This was a retrospective study comparing the inhospital growth of infants born between 30 and 326/7 weeks' gestational age (GA) admitted to the Montefiore Weiler and Wakefield neonatal intensive care units between January 2009 and December 2015. Antibiotic duration during the first week of life was classified as no antibiotics, <5 days of antibiotics, or ≥5 days of antibiotics. Differences between discharge and birth weight Z-scores were compared between the three groups using analysis of variance.

Results Of the infants, 87% received antibiotics during the first week of life, with 16% of infants completing ≥5 days. Compared with infants receiving ≤ 5 days of antibiotics, infants treated with ≥5 days had a lower GA, lower Apgar scores, more invasive respiratory support, longer duration of total parenteral nutrition, delayed initiation of enteral feeding, and a higher weight Z-score on admission and discharge (p < 0.05). However, there was no distinction in growth between the three groups assessed by the difference between admission and discharge weight Z-scores (p = 0.64), growth velocity (gram/kilogram/day) (p = 0.104), or an exponential growth velocity outcome (p = 0.423).

Conclusion Early antibiotic exposure was not associated with increased growth velocity between birth and discharge. Our study was limited by its retrospective nature and lack of follow-up data postdischarge.

Keywords

growth - antibiotics - prematurity - metabolic syndrome
 

  • References

  • 1 Lapillonne A, Griffin IJ. Feeding preterm infants today for later metabolic and cardiovascular outcomes. J Pediatr 2013; 162 (3, Suppl): S7-S16
    CrossrefPubMedGoogle Scholar
  • 2 Thomas E, Al Saud NB, Durighel G, Frost G, Bell JD. The effect of preterm birth on adiposity and metabolic pathways and the implications for later life. Clin Lipidol 2012; 7: 275-288
    CrossrefPubMedGoogle Scholar
  • 3 Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35 (07) 595-601
    CrossrefPubMedGoogle Scholar
  • 4 Barker DJ, Eriksson JG, Forsén T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31 (06) 1235-1239
    CrossrefPubMedGoogle Scholar
  • 5 Barker DJ, Osmond C, Forsén TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005; 353 (17) 1802-1809
    CrossrefPubMedGoogle Scholar
  • 6 Finken MJ, Keijzer-Veen MG, Dekker FW. , et al; Dutch POPS-19 Collaborative Study Group. Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia 2006; 49 (03) 478-485
    CrossrefPubMedGoogle Scholar
  • 7 Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes 2013; 37 (01) 16-23
    CrossrefPubMedGoogle Scholar
  • 8 Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr 2014; 168 (11) 1063-1069
    CrossrefPubMedGoogle Scholar
  • 9 Charbonneau MR, O'Donnell D, Blanton LV. , et al. sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 2016; 164 (05) 859-871
    CrossrefPubMedGoogle Scholar
  • 10 Cox LM, Yamanishi S, Sohn J. , et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014; 158 (04) 705-721
    CrossrefPubMedGoogle Scholar
  • 11 Turta O, Rautava S. Antibiotics, obesity and the link to microbes-what are we doing to our children?. BMC Med 2016; 14: 57-62
    CrossrefPubMedGoogle Scholar
  • 12 Tanaka S, Kobayashi T, Songjinda P. , et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol 2009; 56 (01) 80-87
    CrossrefPubMedGoogle Scholar
  • 13 Dardas M, Gill SR, Grier A. , et al. The impact of postnatal antibiotics on the preterm intestinal microbiome. Pediatr Res 2014; 76 (02) 150-158
    CrossrefPubMedGoogle Scholar
  • 14 Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin Jr DK, Smith PB. ; Best Pharmaceuticals for Children Act—Pediatric Trials Network. Medication use in the neonatal intensive care unit. Am J Perinatol 2014; 31 (09) 811-821
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003; 3: 13-22
    CrossrefPubMedGoogle Scholar
  • 16 Patel AL, Engstrom JL, Meier PP, Kimura RE. Accuracy of methods for calculating postnatal growth velocity for extremely low birth weight infants. Pediatrics 2005; 116 (06) 1466-1473
    CrossrefPubMedGoogle Scholar
  • 17 Patel AL, Engstrom JL, Meier PP, Jegier BJ, Kimura RE. Calculating postnatal growth velocity in very low birth weight (VLBW) premature infants. J Perinatol 2009; 29 (09) 618-622
    CrossrefPubMedGoogle Scholar
  • 18 Cotten CM, Taylor S, Stoll B. , et al; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123 (01) 58-66
    CrossrefPubMedGoogle Scholar
  • 19 Puopolo KM, Mukhopadhyay S, Hansen NI. , et al; NICHD Neonatal Research Network. Identification of extremely premature infants at low risk for early-onset sepsis. Pediatrics 2017; 140 (05) e20170925
    CrossrefPubMedGoogle Scholar
  • 20 Parkinson JRC, Hyde MJ, Gale C, Santhakumaran S, Modi N. Preterm birth and the metabolic syndrome in adult life: a systematic review and meta-analysis. Pediatrics 2013; 131 (04) e1240-e1263
    CrossrefPubMedGoogle Scholar
  • 21 Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol 2012; 36 (06) 431-436
    CrossrefPubMedGoogle Scholar
  • 22 Mongkolrattanothai K, Chin S, Srikumar N. , et al. Antimicrobial stewardship in the neonatal intensive care unit (NICU): building and sustaining the effective collaboration. Open Forum Infect Dis 2016; 3: 1914
    CrossrefPubMedGoogle Scholar
  • 23 Tabb E, Fallaha J, Storey I, Hussain A. G63(P) Antimicrobial stewardship on a neonatal intensive care unit (NICU) in the UK. Arch Dis Child 2016; 101: A35-A36
    PubMedGoogle Scholar
  • 24 Ramasethu J, Kawakita T. Antibiotic stewardship in perinatal and neonatal care. Semin Fetal Neonatal Med 2017; 22 (05) 278-283
    CrossrefPubMedGoogle Scholar